Here you can find the NEWSLETTER archive More ...
HJM C-Tec Buchta MT-Messtechnik
cleanroom online
Deutsch   English

All publications for the rubric New building

Susanne Geistlich, Leiterin der klinischen Medikamentenversorgung am PSI, während der Arbeit an einer der Abfüllanlagen im neuen Pharmalabor. In einer solchen Zelle werden die Radiopharmazeutika in Injektionsflaschen gefüllt. Die aseptische Umgebung sowie ein spezielles Filtersystem sorgen für ein keimfreies Produkt. (Foto: Paul Scherrer Institut/Mahir Dzambegovic) / Susanne Geistlich, head of the Clinical Drug Supply Group at PSI, working at one of the filling systems at the new pharmaceutical laboratory. In these cells, vials are filled with the radiopharmaceuticals. The aseptic environment and a special filter system ensure a sterile product. (Photo: Paul Scherrer Institute/Mahir Dzambegovic) Susanne Geistlich prüft eine Probe des Hygiene-Monitorings auf Sterilität. Die aseptische Herstellung von sterilen Arzneimitteln verlangt effektive Hygienemassnahmen in den Räumen und beim Personal. (Foto: Paul Scherrer Institut/Mahir Dzambegovic) / Susanne Geistlich checks a hygiene-monitoring sample for sterility. The aseptic production of sterile medicines demands effective hygienic measures in the rooms and among the staff. (Photo: Paul Scherrer Institute/Mahir Dzambegovic)
  • ‌
  • New building

The new pharmaceutical laboratory for the manufacture of radiopharmaceuticals at PSI is ready for production. With its three state-of-the-art production units, novel and innovative drugs can be brought rapidly into clinical use.

Swissmedic grants operating licence for new radiopharmaceutical production facility

At PSI, with the help of a new facility, small batches of highly specific drugs will be produced in future. These will be delivered directly to hospitals for use in treating tumour patients.

For more than 20 years, in collaboration with ETH Zurich, PSI researchers have been developing new drugs for t…
Blick in die Reinraumfertigung im Bosch Halbleiterwerk in Dresden. (Foto: Bosch) / View into the clean room production at the Bosch semiconductor plant in Dresden. (Picture: Bosch) Blick in die Reinraumfertigung im Bosch Halbleiterwerk in Dresden. (Foto: Bosch) / View into the clean room production at the Bosch semiconductor plant in Dresden. (Picture: Bosch) Ein Applikationsingenieur prüft im Bosch Halbleiterwerk in Dresden Heizkassetten für Hochtemperaturöfen. (Foto: Bosch) / An application engineer checks heating cassettes for high-temperature furnaces at the Bosch semiconductor plant in Dresden, Germany. (Picture: Bosch) Halbleiterfertigung von Bosch in Dresden: Um seine führende Marktposition in der Mikromechanik weiter auszubauen, wird Bosch MEMS-Sensoren in Zukunft auch auf 300-Millimeter-Wafern fertigen. Der Produktionsstart ist für 2026 geplant. (Foto: Bosch) / Bosch wafer fab in Dresden: To cement its leading market position in micromechanics, Bosch also plans to manufacture its MEMS sensors on 300-millimeter wafers. Production is scheduled to start in 2026. (Picture: Bosch) Halbleiterfertigung von Bosch in Dresden: Bosch ist das führende Unternehmen in der Automobilindustrie, das Halbleiter sowohl für Automobilanwendungen als auch für die Konsumentengüter-Industrie selbst entwickelt und produziert. In Reutlingen seit 50 Jahren auf Basis der 150- und 200-Millimeter-Technologie, in Dresden seit 2021 auf Basis von 300-Millimeter-Wafer. (Foto: Bosch) / Bosch wafer fab in Dresden: Bosch is the automotive industry’s leading company for the development and manufacture of semiconductors that are used in automotive applications as well as the consumer goods industry. It has been producing these chips in Reutlingen for 50 years on 150- and 200-mm wafers, and in Dresden since 2021 on 300-mm wafers. (Picture: Bosch) Die Halbleiterfertigung zählt zu den Vorreitern einer vernetzten Produktion. Nur zur Wartung greifen Menschen in die Produktion ein: Wenn bei der Signaturanalyse Fehler entdeckt werden, wird der Roboterarm nachgestellt – der KI-Algorithmus stellt fest, wann ein Eingreifen nötig ist, der Mensch entscheidet über die genaue Anpassung. (Foto: Bosch) / Wafer production is one of the forerunners of connected manufacturing. Humans only intercede in the production process for maintenance purposes. They readjust the robot arm when the signature analysis detects flaws. The AI algorithm determines when intervention is necessary; humans decide what needs adjusting. (Picture: Bosch) Bosch nutzt im Dresdner Halbleiterwerk Augmented Reality (AR). Dank smarter AR-Datenbrillen oder Tablets werden Nutzern digitale Inhalte in die reale Umgebung eingeblendet. (Foto: Bosch) / In its Dresden plant, Bosch is making use of augmented reality (AR). Thanks to smart AR glasses and tablets, users will be able to see digital content superimposed on the real environment. (Picture: Bosch)
  • ‌
  • New building

Microelectronics is vital to the success of all areas of Bosch business

“Invented for life” with semiconductors: Bosch invests further billions in chip business

– Bosch to invest 3 billion euros in its semiconductor business by 2026 as part of the IPCEI on Microelectronics and Communications Technology
– Bosch chairman Dr. Stefan Hartung: “Microelectronics is the future.”
– New chip development centers under construction in Reutlingen and Dresden

From cars and e-bi…
Endress+Hauser fertig in Cernay/Frankreich auf insgesamt 37.000 Quadratmetern Durchflussmessgeräte. / In Cernay, France, Endress+Hauser produces flowmeters across a total of 37,000 square meters. Endress+Hauser hat in Cernay ein neues Produktions- und Bürogebäude eingeweiht. / Endress+Hauser dedicated a new production and office building in Cernay, France.
  • ‌
  • New building

In order to meet the growing demand for flow instrumentation, the company has opened a new production and office building.

Endress+Hauser dedicates new facility in France

Endress+Hauser manufactures flowmeters in Cernay for delivery to customers around the world. “Cernay is one of the Group’s fastest growing locations and has already been expanded nine times since it went into operation in 1991,” says Matthias Altendorf, CEO of the Endress+Hauser Group at the d…
  • ‌
  • Company

Merck is expanding its membrane and filtration manufacturing capabilities in Ireland. The company will invest approximately €440 million.

Merck Invests More Than €440 Million and Expands its Membrane and Filtration Manufacturing in Ireland

– Company to invest in two major Life Science projects over five years
– Significantly increases membrane manufacturing capacities and enables construction of new filtration manufacturing facility
– Supports Merck’s strategy to invest in products and technologies across its portfolio that are key to…
A look at the NEWSLETTER

Better informed: With YEARBOOK, NEWSLETTER, NEWSFLASH and EXPERT DIRECTORY

Stay up to date and subscribe to our monthly eMail-NEWSLETTER and our NEWSFLASH. Get additional information about what is happening in the world of cleanrooms with our printed YEARBOOK. And find out who the cleanroom EXPERTS are with our directory.

Becker PPS Systec & Solutions GmbH Vaisala